CVS Health (CVS) PT Raised to $118 at JPMorgan
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $97.20 -0.03%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
JPMorgan analyst Lisa Gill raised the price target on CVS Health (NYSE: CVS) to $118.00 (from $111.00) while maintaining a Overweight rating.
You May Also Be Interested In
- CVS Health (CVS) PT Lowered to $118 at UBS
- Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S.
- JPMorgan Downgrades ZTO Express Cayman (2057:HK) (ZTO) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
